European Medicines Agency

@ema.europa.eu

EU regulatory authority working for public and animal health.
We ensure that all medicines available on the EU market are high quality, safe and effective. Based in Amsterdam.
https://www.ema.europa.eu/

@ema.europa.eu Oct 8, 2026, 3:28 PM

📢 From January 2027, a pilot helping sponsors develop stronger clinical trial applications in the EU will become a permanent initiative. This is known as the Accelerating Clinical Trials in the EU (ACT EU) advice 🔗 Learn more www.ema.europa.eu/en/news/clin... #PublicHealth #medsky 🧪 #SciComm

@ema.europa.eu Sep 30, 2026, 12:16 PM

🧪 EMA will develop a roadmap by end-2026 to drive change in how women’s health is considered in medicines development and regulation. It follows a workshop with 100+ experts and stakeholders. Read more: www.ema.europa.eu/en/news/wome...
#medsky #womenshealth

@ema.europa.eu Sep 29, 2026, 1:49 PM

❤️ This World Heart Day, hear personal experiences of living with heart conditions, alongside simple tips on how to look after your heart and take care of your cardiovascular health.

Learn more about the EMA workshop: www.ema.europa.eu/en/events/em...

@ema.europa.eu Sep 24, 2026, 8:17 AM

Discover our new pharmacogenomics webpage, featuring information on how genetic variation can influence a response to medicines. Explore data from centrally authorised medicines and scientific guidance for medicine developers 🔗 www.ema.europa.eu/en/human-reg... #PublicHealth #medsky 🧪 #SciComm

@ema.europa.eu Sep 22, 2026, 8:57 AM

🌿 Herbal medicines have a long history. Watch the joint FDA/EMA workshop on herbal medicinal and botanical products to find out how regulators ensure their quality, safety and good use

📺 www.ema.europa.eu/en/events/re...
@fda.gov

@ema.europa.eu Sep 21, 2026, 11:30 AM

EMA experts explore why we shouldn't focus on setting a requirement for a number of clinical trials.

One pivotal trial, or two? What matters is generating evidence that addresses patients’ needs and supports a positive benefit–risk balance.

Read the article: www.nature.com/articles/s41...

@ema.europa.eu Sep 21, 2026, 7:10 AM

Both studies were conducted through DARWIN EU, the network that uses real-world healthcare data from across Europe to generate evidence that can support decisions about medicines.

Find out more: www.ema.europa.eu/en/about-us/...

@ema.europa.eu Sep 21, 2026, 7:09 AM

What happens after diagnosis? A second looked at treatments received following an Alzheimer’s diagnosis and outcomes including healthcare use, hospitalisations, caregiver support, nursing home or hospice admission and survival. 🔗https://catalogues.ema.europa.eu/node/4731/administrative-details

@ema.europa.eu Sep 21, 2026, 7:08 AM

Who is affected by Alzheimer’s disease? One study looked at the incidence and prevalence of Alzheimer’s disease, as well as the demographic and clinical characteristics of people newly diagnosed using data from 5 countries. 🔗https://catalogues.ema.europa.eu/node/4730/administrative-details

@ema.europa.eu Sep 21, 2026, 7:07 AM

On World Alzheimer's Day, we’re highlighting two studies commissioned by EMA that use real-world healthcare data to better understand Alzheimer’s disease, from who is affected to what happens after diagnosis.

Keep reading the thread👇

🧪 #medsky #Scicomm

@ema.europa.eu Sep 18, 2026, 10:37 AM

📢 EMA recommends: 12 new medicines for approval, including four medicines for cancer. Read more here:
🔗 www.ema.europa.eu/en/news/meet... #PublicHealth #medsky 🧪 #SciComm

@ema.europa.eu Sep 17, 2026, 12:03 PM

Did you know some foods and drinks can affect how your medicine works? 🍊☕🍌

Your package leaflet tells you what to be mindful of, including foods, drinks and alcohol. When in doubt, ask your pharmacist or doctor.

Keep safe. Read the leaflet.🧪 #SciComm

Learn more: www.ema.europa.eu/en/about-us/...

@ema.europa.eu Sep 14, 2026, 2:10 PM

The agenda of EMA's human medicines committee #CHMP is now published. Find out what medicines will be discussed this month 💊💉 www.ema.europa.eu/en/events/co... The committee highlights will be released on Friday.

@ema.europa.eu Sep 7, 2026, 12:34 PM

What are we doing for women’s health? We’re working to ensure women’s needs are considered in medicine development, evaluation and use, for a wide range of areas: from #endometriosis to #pregnancy and #menopause. Learn more here.
www.ema.europa.eu/en/human-reg...
#medsky 🧪 #womenshealth

@ema.europa.eu Sep 4, 2026, 1:05 PM

We have just started a review of injectable iron-containing medicines following concerns about the risk of low blood phosphate levels and related bone problems.

Find out more in #PRAC highlights: www.ema.europa.eu/en/news/meet...

@ema.europa.eu Sep 4, 2026, 9:25 AM

Good news!

A new EU supply chain has been put in place to end the shortage of Visudyne, a medicine used to treat adults with certain serious eye conditions, which will ensure access to patients across the EU.

Find out more more: www.ema.europa.eu/en/news/new-...

@ema.europa.eu Sep 3, 2026, 1:49 PM

🎙️ New #InsideEMA episode!

What is it like to be an EMA trainee?

From regulatory science and policy to learning, networking and life in Amsterdam, current trainees share their experience of working at the European Medicines Agency. 🎧 💊 🌍

@ema.europa.eu Sep 1, 2026, 12:12 PM

🚀 We are launching a new voluntary data submission pilot for innovative alternatives to animal testing. Companies can submit data generated using new approach methodologies and receive tailored scientific feedback from EMA 👉 www.ema.europa.eu/en/news/volu... #PublicHealth #medsky 🧪 #SciComm

@ema.europa.eu Aug 13, 2026, 8:53 AM

“We need to think about strategies to make #vaccination easier, not more complicated,” said Marco Cavaleri, our head of public-health threats, in a Nature article on combined MMR vaccines versus separate #measles, mumps and rubella shots in children. Read more: www.nature.com/articles/d41... 🧪

nature.comTrump wants MMR vaccine split up: the science behind why it’s a bad ideaNumerous studies have shown that separating childhood jabs will delay protection and increase costs for families.